India’s New IPR Policy: Balanced And Evolving?

India’s new National Intellectual Property Rights policy appears to have steered clear of a host of prickly issues pertaining to the pharmaceutical industry for now, while standing firm on the need for "strong measures" against attempts to treat generic drugs as "spurious or counterfeit".